Milestone Scientific (NYSE:MLSS) Stock Price Down 2.3% – What’s Next?

Milestone Scientific Inc. (NYSE:MLSS)’s share price traded down 2.3% on Monday . The company traded as low as $0.2875 and last traded at $0.2969. 141,172 shares traded hands during trading, a decline of 62% from the average session volume of 371,079 shares. The stock had previously closed at $0.3038.

Analyst Ratings Changes

Separately, Benchmark cut their price target on Milestone Scientific from $1.25 to $1.00 and set a “speculative buy” rating on the stock in a report on Thursday, November 20th. One analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, Milestone Scientific currently has a consensus rating of “Buy” and an average price target of $1.00.

Milestone Scientific Stock Performance

The firm’s 50 day moving average is $0.31 and its 200 day moving average is $0.45. The stock has a market cap of $23.34 million, a P/E ratio of -4.24 and a beta of 0.89.

Institutional Trading of Milestone Scientific

An institutional investor recently raised its position in Milestone Scientific stock. Raymond James Financial Inc. lifted its holdings in Milestone Scientific Inc. (NYSE:MLSS) by 416.7% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 62,000 shares of the company’s stock after purchasing an additional 50,000 shares during the quarter. Raymond James Financial Inc. owned about 0.08% of Milestone Scientific worth $39,000 as of its most recent SEC filing. Institutional investors and hedge funds own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific, Inc, listed on the New York Stock Exchange under the symbol MLSS, is a medical device company specializing in the development and commercialization of computer-controlled injection technologies for local anesthesia and pain management. The company’s proprietary systems are designed to enhance patient comfort, improve clinical outcomes and streamline the administration of anesthetics in dental and medical procedures. Through its precision delivery platforms, Milestone Scientific aims to set a new standard for minimally invasive injections.

At the core of Milestone Scientific’s product portfolio is the Single Tooth Anesthesia (STA) System, which uses Comunication Controlled Local Anesthetic Delivery (CCLAD) technology to provide targeted, atraumatic anesthesia for individual dental roots.